Research Article
The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients
Table 6
Outcomes for patients with CAEs in patients by serum magnesium target group.
| | Patients with CAEs—with serum () | Patients with CAE—with serum () | value |
| Early outcomes | | | | Nurse GCS, median (IQR) | 13 (10-15) | 15 (12-15) | 0.04 | Nurse LAMS, median (IQR) | 5 (3-5) | 5 (3-5) | 0.68 | Nurse NIHSS, mean (SD) | 17.1 (10.4) | 14.3 (8.6) | 0.08 | 90-day outcomes | | | | mRS 90 d 0-1, (%) | 3 (6.4) | 20 (18.0) | 0.08 | mRS 90 d 0-2, (%) | 30 (27.0) | 9 (19.1) | 0.32 | mRS 90 d, mean (SD) | 4.4 (1.8) | 4.0 (2.1) | 0.26 | Mortality 90 d, (%) | 18 (38.3) | 41 (36.6) | 0.85 |
|
|